Systemic and local interleukin-17 and linked cytokines associated with Sjogren's syndrome immunopathogenesis.
|
Katsifis GE, et. al.
|
Am J Pathol |
175 (2009) |
Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.
|
Bock O, et. al.
|
Br J Haematol |
146 (2009) |
Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients.
|
Ashton-Chess J, et. al.
|
J Am Soc Nephrol |
20 (2009) |
View More Citations ...View Less... |
The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
|
Scholz H, et. al.
|
Diabetologia |
52 (2009) |
HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.
|
Oswald-Richter K, et. al.
|
Plos Biol |
2 (2004) |
Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells.
|
Wang R, et. al.
|
Proc Natl Acad Sci U S A |
106 (2009) |
Decreased FOXP3 levels in multiple sclerosis patients.
|
Huan J, et. al.
|
J Neurosci Res |
81 (2005) |
New means to monitor the effect of glucocorticoid therapy in children.
|
Rintamaki H, et. al.
|
World J Gastroenterol |
16 (2010) |
FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients.
|
Dijke IE, et. al.
|
Transpl Immunol |
18 (2008) |
The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.
|
Li Y, et. al.
|
Transplantation |
86 (2008) |
CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients.
|
Velthuis JH, et. al.
|
Am J Transplant |
6 (2006) |
Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
|
Lucas JL, et. al.
|
Cell Immunol |
257 (2009) |
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation.
|
Vlad G, et. al.
|
Transpl Immunol |
18 (2007) |
CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
|
Kumar M, et. al.
|
J Neuroimmunol |
180 (2006) |
Functional CD25(bright+) alloresponsive T cells in fully immunosuppressed renal allograft recipients.
|
Baan CC, et. al.
|
Clin Transplant |
21 (2007) |
Expression patterns of regulatory T-cell markers in accepted and rejected nonhuman primate kidney allografts.
|
Haanstra KG, et. al.
|
Am J Transplant |
7 (2007) |
Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients.
|
Dijke IE, et. al.
|
Transplantation |
83 (2007) |
Regulatory T cell-associated activity in photopheresis-induced immune tolerance in recent onset type 1 diabetes children.
|
Jonson CO, et. al.
|
Clin Exp Immunol |
153 (2008) |
Infiltration of Foxp3- and Toll-like receptor-4-positive cells in the intestines of children with food allergy.
|
Westerholm-Ormio M, et. al.
|
J Pediatr Gastroenterol Nutr |
50 (2010) |
Poor in vitro induction of FOXP3 and ICOS in type 1 cytokine environment activated T-cells from children with type 1 diabetes.
|
Honkanen J, et. al.
|
Diabetes Metab Res Rev |
24 (2008) |
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells.
|
Valencia X, et. al.
|
Blood |
108 (2006) |
Dynamic T-lymphocyte chemokine receptor expression induced by interferon-beta therapy in multiple sclerosis.
|
Krakauer M, et. al.
|
Scand J Immunol |
64 (2006) |
Molecular evidence of injury and inflammation in normal and fibrotic renal allografts one year posttransplant.
|
Park W, et. al.
|
Transplantation |
83 (2007) |
End-stage renal failure and regulatory activities of CD4+CD25bright+FoxP3+ T-cells.
|
Hendrikx TK, et. al.
|
Nephrol Dial Transplant |
24 (2009) |
Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma.
|
Tiemessen MM, et. al.
|
J Invest Dermatol |
126 (2006) |
Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.
|
Xystrakis E, et. al.
|
J Clin Invest |
116 (2006) |
Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus.
|
Vorobjova T, et. al.
|
Scand J Gastroenterol |
44 (2009) |
Insulin treatment in patients with type 1 diabetes induces upregulation of regulatory T-cell markers in peripheral blood mononuclear cells stimulated with insulin in vitro.
|
Tiittanen M, et. al.
|
Diabetes |
55 (2006) |
Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor.
|
Condomines M, et. al.
|
J Immunol |
176 (2006) |
Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
|
Sewgobind VD, et. al.
|
Transplantation |
89 (2010) |
Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection.
|
Antons AK, et. al.
|
J Immunol |
180 (2008) |
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia.
|
Ruprecht CR, et. al.
|
J Exp Med |
201 (2005) |
High expression of Foxp3, IL-23p19 and survivin mRNA in colorectal carcinoma.
|
Stanilov N, et. al.
|
Int J Colorectal Dis |
24 (2009) |
Histamine 4 receptor activation induces recruitment of FoxP3+ T cells and inhibits allergic asthma in a murine model.
|
Morgan RK, et. al.
|
J Immunol |
178 (2007) |
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells.
|
Koenen HJ, et. al.
|
Blood |
112 (2008) |
Novel insight into the agonistic mechanism of alefacept in vivo: differentially expressed genes may serve as biomarkers of response in psoriasis patients.
|
Haider AS, et. al.
|
J Immunol |
178 (2007) |
FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes.
|
Scotta C, et. al.
|
J Immunol |
181 (2008) |
Ability of mature dendritic cells to interact with regulatory T cells is imprinted during maturation.
|
Muthuswamy R, et. al.
|
Cancer Res |
68 (2008) |